"When asked if Trump was the 79-year-old man in question, White House spokesperson Kush Desai did not say no...."

From TNR.

"The Alzheimer’s treatment donanemab, which is made by Eli Lilly, significantly slowed progression of the mind-robbing disease..."

"... according to clinical trial data released Wednesday by the company. Patients who received the monthly antibody infusion during an 18-month study demonstrated a 35% slower decline in memory, thinking and their ability to perform daily activities compared to those who did not receive the treatment, Eli Lilly’s data showed."

CNBC reports.